U.S. Bancorp in Brief

It's been a great morning session for U.S. Bancorp investors, who saw their shares rise 2.1% to a price of $35.88 per share. At these higher prices, is the company still fairly valued? If you are thinking about investing, make sure to check the company's fundamentals before making a decision.

U.S. Bancorp Has Attractive Multiples and Trades Below Its Graham Number:

U.S. Bancorp, a financial services holding company, provides various financial services to individuals, businesses, institutional organizations, governmental entities and other financial institutions in the United States. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 14.34 and an average price to book (P/B) ratio of 1.57. In contrast, U.S. Bancorp has a trailing 12 month P/E ratio of 10.0 and a P/B ratio of 1.19.

U.S. Bancorp's PEG ratio is 1.32, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

EPS Trend Sustained Primarily by Reducing the Number of Shares Outstanding:

2018-02-22 2019-02-22 2020-02-20 2021-02-23 2022-02-22 2023-02-27
Revenue (MM) $21,697 $22,521 $22,883 $23,226 $22,721 $24,184
Operating Margins 35% 39% 38% 26% 45% 30%
Net Margins 28% 32% 30% 21% 35% 24%
Net Income (MM) $6,218 $7,096 $6,914 $4,959 $7,963 $5,825
Earnings Per Share $3.51 $4.14 $4.16 $3.28 $5.28 $3.86
EPS Growth n/a 17.95% 0.48% -21.15% 60.98% -26.89%
Diluted Shares (MM) 1,683 1,638 1,583 1,510 1,509 1,510
Long Term Debt (MM) $32,259 $41,340 $40,167 $41,297 $32,125 $39,829
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.